| Literature DB >> 31364565 |
N Sopena1, N Freixas2, F Bella2, J Pérez2, A Hornero2, E Limon2, F Gudiol2, M Pujol2.
Abstract
A high degree of vigilance and appropriate diagnostic methods are required to detect Clostridioides difficile infection (CDI). We studied the effectiveness of a multimodal training program for improving CDI surveillance and prevention. Between 2011 and 2016, this program was made available to healthcare staff of acute care hospitals in Catalonia. The program included an online course, two face-to-face workshops and dissemination of recommendations on prevention and diagnosis. Adherence to the recommendations was evaluated through surveys administered to the infection control teams at the 38 participating hospitals. The incidence of CDI increased from 2.20 cases/10 000 patient-days in 2011 to 3.41 in 2016 (P < 0.001). The number of hospitals that applied an optimal diagnostic algorithm rose from 32.0% to 71.1% (P = 0.002). Hospitals that applied an optimal diagnostic algorithm reported a higher overall incidence of CDI (3.62 vs. 1.92, P < 0.001), and hospitals that were more active in searching for cases reported higher rates of hospital-acquired CDI (1.76 vs. 0.84, P < 0.001). The results suggest that the application of a multimodal training strategy was associated with a significant rise in the reporting of CDI, as well as with an increase in the application of the optimal diagnostic algorithm.Entities:
Keywords: Clostridioides difficile; Clostridium difficile; infection prevention; medical education; surveillance
Year: 2019 PMID: 31364565 PMCID: PMC6625180 DOI: 10.1017/S0950268819001080
Source DB: PubMed Journal: Epidemiol Infect ISSN: 0950-2688 Impact factor: 2.451
Evolution of rates of Clostridioides difficile infection and of the number of hospitals participating in the surveillance program
| 2011 (29 hospitals) MIa (95%CI) | 2012 (34 hospitals) MIa (95%CI) | 2013 (37 hospitals) MIa (95%CI) | 2014 (43 hospitals) MIa (95%CI) | 2015 (45 hospitals) MIa (95%CI) | 2016 (47 hospitals) MIa (95%CI) | ||
|---|---|---|---|---|---|---|---|
| Overall CDI | 2.20 (2.00–2.40) | 2.38 (2.19–2.57) | 2.65 (2.45–2.85) | 3.34 (3.13–3.54) | 3.62 (3.41–3.83) | 3.41 (3.21–3.61) | <0.001 |
| Hospital-acquired CDI | 0.98 (0.85–1.11) | 1.11 (0.97–1.24) | 1.16 (1.02–1.29) | 1.49 (1.35–1.62) | 1.45 (1.41–1.68) | 1.57 (1.43–1.70) | 0.001 |
| Non-nosocomial healthcare-related CDI | 0.77 (0.65–0.89) | 0.72 (0.61–0.82) | 0.87 (0.75–0.98) | 1.07 (0.95–1.18) | 1.09 (0.97–1.20) | 0.95 (0.84–1.06) | 0.028 |
| Community-acquired CDI | 0.45 (0.36–0.54) | 0.55 (0.46–0.65) | 0.63 (0.53–0.72) | 0.78 (0.68–0.89) | 0.99 (0.88–1.10) | 0.89 (0.79–0.99) | 0.001 |
CDI, Clostridioides difficile infection.
aMean incidence: cases/10 000 patient-days.
Evolution of rates of Clostridioides difficile infection in the 29 hospitals participating in the surveillance program from 2011 to 2016
| 2011 MIa (95%CI) | 2012 MIa (95%CI) | 2013 MIa (95%CI) | 2014 MIa (95%CI) | 2015 MIa (95%CI) | 2016 MIa (95%CI) | ||
|---|---|---|---|---|---|---|---|
| Overall CDI | 2.26 (2.06–2.47) | 2.49 (2.28–2.71) | 2.72 (2.49–2.96) | 3.30 (3.06–3.55) | 3.54 (3.28–3.79) | 3.27 (3.03–3.51) | <0.001 |
| Hospital-acquired CDI | 1.01 (0.88–1.15) | 1.14 (1.00–1.29) | 1.24 (1.09–1.40) | 1.54 (1.37–1.71) | 1.58 (1.41–1.75) | 1.47 (1.30–1.63) | 0.003 |
| Non-nosocomial healthcare-related CDI | 0.78 (0.66–0.90) | 0.79 (0.67–0.91) | 0.91 (0.77–1.04) | 1.02 (0.88–1.15) | 1.09 (0.95–1.23) | 0.98 (0.85–1.11) | 0.028 |
| Community-acquired CDI | 0.47 (0.37–0.56) | 0.56 (0.46–0.67) | 0.57 (0.47–0.68) | 0.76 (0.64–0.87) | 0.86 (0.74–0.99) | 0.82 (0.70–0.94) | 0.004 |
CDI, Clostridioides difficile infection.
aMean incidence: cases/10 000 patient-days.
Survey of diagnosis and preventive measures (2011 vs. 2016)
| 2011 (25 hospitals) | 2016 (38 hospitals) | ||
|---|---|---|---|
| CDI study in >80% of episodes of hospital-onset diarrhoea | 16 (64.0) | 23 (60.5) | 0.78 |
| CDI study in >50% of episodes of community-onset diarrhoea with history of antibiotic treatment | 18 (72.0) | 31 (81.2) | 0.37 |
| CDI study in >50% of episodes of diarrhoea in patients admitted from nursing homes or community healthcare centres | 9 (36.0) | 22 (57.9) | 0.08 |
| Only liquid or semiliquid faeces processed for CDI study | 25 (100) | 37 (97.4) | 1.00 |
| All the samples for CDI study sent to the laboratory in a bottle (not in a swab) | 24 (96.0) | 37 (97.4) | 1.00 |
| Optimal microbiological diagnostic methodologya | 8 (32.0) | 27 (71.1) | 0.002 |
| Availability of centre's own protocol on diagnosis and preventive measures | 15 (60.0) | 25 (65.8) | 0.64 |
| Daily notification by the Microbiology Service of positive results for | 23 (92.0) | 35 (92.1) | 1.00 |
| Introduction of contact precautions in all cases of CDI | 25 (100) | 38 (100) | NS |
| Recommendation to wash hands with soap and water instead of alcohol | 23 (92.0) | 38 (100) | 0.15 |
| Duration of precautions at least 48–72 h after the end of diarrhoea | 21 (84.0) | 34 (89.5) | 0.70 |
| Consideration of whether to suspend antibiotic treatment | 25 (100) | 38 (100) | NS |
| Consideration of whether to suspend antacid treatment | 1 (4.0) | 9 (23.7) | 0.07 |
| No post-treatment microbiological control performed in patients diagnosed with CDI | 19 (76.0) | 34 (89.5) | 0.17 |
CDI, Clostridioides difficile infection.
NS, not significant.
aThe diagnostic method was considered optimal when a diagnostic algorithm including two or more methods of detection of toxigenic C. difficile was applied.